Therapeutic anti-cancer vaccines: a systematic review of prospective intervention trials for common hematological malignanciesResearch in context

QR Code

Therapeutic anti-cancer vaccines: a systematic review of prospective intervention trials for common hematological malignanciesResearch in context

Summary: Background: This review comprehensively assesses all prospective trials on anti-cancer vaccines for common hematological malignancies by analyzing trial designs, endpoints, and whether these endpoints are met across these trials. Methods: We included onco prospective clinical trials involv...

Full description

Saved in:

Bibliographic Details
Main Authors:	Darshi Shah, Veer Shah, Karan Shah, Prachi J. Shah, Muatassem Alsadhan, Alyson Haslam, Vinay Prasad, Muzaffar H. Qazilbash, Rajshekhar Chakraborty, Ghulam Rehman Mohyuddin
Format:	Article
Language:	English
Published:	Elsevier 2025-08-01
Series:	EClinicalMedicine
Subjects:	Systematic review Cancer vaccines Hematological malignancies
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589537025003104
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Advanced molecular diagnostics: Driving precision in hematological malignancies
by: Li Bao, et al.
Published: (2025-07-01)

Cutaneous Manifestations of Pediatric Hematological Malignancies: A Narrative Review
by: Ananya Pramanik, et al.
Published: (2025-04-01)

Role of lactate dehydrogenase A in malignant hematological diseases
by: MO Yuzhen, CHEN Tingting, ZHOU Hebing
Published: (2025-07-01)

Second tumors in children with hematological malignancies
by: N. A. Susuleva, et al.
Published: (2021-04-01)

Erythropoietin for the treatment of anemia in patients with hematologic disorders
by: R. A. Podgurskaya, et al.
Published: (2022-11-01)

FOXP1 is associated with oncogenesis and clinical outcomes in hematologic malignancies
by: Xiang-mei Wen, et al.
Published: (2025-07-01)

State of immune status in hematological patients with invasive aspergillosis
by: E. V. Frolova, et al.
Published: (2014-09-01)

Radiologic diagnosis of pulmonary infection lesions in patients with hematologic malignancies
by: T. R. Alekseeva
Published: (2022-11-01)

Current Advances and Challenges in CAR-T Therapy for Hematological and Solid Tumors
by: Zhang G, et al.
Published: (2025-06-01)

Veterinary hematology
by: Schalm, O. W. (Oscar William), 1909-
Published: (1975)

Precision Medicine in Hematologic Malignancies: Evolving Concepts and Clinical Applications
by: Rita Khoury, et al.
Published: (2025-07-01)

Current advances in the role of classical non‐homologous end joining in hematologic malignancies
by: Pengcheng Liu, et al.
Published: (2025-06-01)

Global, regional, and national economic burden of hematologic malignancies (1990–2021) with projections to 2050
by: Zhexian Li, et al.
Published: (2025-06-01)

Assessment of red cell distribution width in patients with hematological malignancy
by: Athmar Khadihm Gatea, et al.
Published: (2025-01-01)

ORGANIZATION OF REHABILITATION ASSISTANCE TO CHILDREN WITH SEVERE DISEASES OF THE BLOOD AND BLOOD-FORMING ORGANS
by: N. G. Petrova, et al.
Published: (2013-12-01)

Future perspectives on novel CAR-T therapeutics beyond CD19 and BCMA in onco-hematology
by: Alina Ershova, et al.
Published: (2025-07-01)

Monitoring of patients with hematological malignancies after anticancer therapy
by: A. E. Rudneva, et al.
Published: (2015-01-01)

Evaluation of Navify Mutation Profiler Tertiary Analysis Software Assessing for Hematologic Malignancies
by: Ruby Singhrao, et al.
Published: (2025-05-01)

Editorial: Immune system interactions in hematological tumor microenvironments: pathways to innovative treatments
by: Elisa Mandato, et al.
Published: (2025-08-01)

Exploring potential causal effects of circulating inflammatory proteins on hematologic malignancies and identifying cross-cancer drug targets: a Mendelian randomization study
by: Chaoqun Lu, et al.
Published: (2025-12-01)

Molecular characterization of extended-spectrum β-lactamase-producing <i>Escherichia coli</i> collected from patients with hematological malignancies during chemotherapy cycles
by: A. G. Korobova, et al.
Published: (2019-04-01)

Real-World Experience with Isavuconazole for Invasive Aspergillosis in Hematologic Patients with and Without COVID-19 in Brazil
by: Larissa Simão Gandolpho, et al.
Published: (2025-06-01)

Cognitive impairments in patients with hematological malignancies prior and after allogeneic hematopoietic stem cells transplantation
by: D. E. Vybornykh, et al.
Published: (2019-07-01)

Genotyping by Random Amplified Polymorphic DNA Assay of Acinetobacter baumannii Isolated from Blood Culture of Patients with Hematological Malignancies
by: S. A. Khrulnova, et al.
Published: (2020-09-01)

The impact of viral infections on the results of hemopoietic stem cell transplantation in patients with hematologic malignancies
by: T. V. Antonova, et al.
Published: (2021-01-01)

Measurable residual disease in hematologic malignancies: a biomarker in search of a standard
by: Namrata S. Chandhok, et al.
Published: (2025-08-01)

Cognitive impairment in patients with hematological malignancies at a long-term period after the transplantation of allogeneic hematopoietic stem cells
by: D. E. Vybornykh, et al.
Published: (2020-04-01)

Impact of administration route and gene polymorphisms on the serum concentration of voriconazole among Chinese patients with hematologic malignancies
by: Zhiyao Chen, et al.
Published: (2025-07-01)

American Society of Hematology. 48th Annual meeting
by: article Editorial
Published: (2022-11-01)

MECHANISMS OF DISTURBED COOPERATION BETWEEN LYMPHOCYTES AND EOSINOPHILS IN HEMOBLASTOSES COMPLICATED WITH EOSINOPHILIC SYNDROME
by: N. V. Ryazantseva, et al.
Published: (2014-07-01)

Invasive aspergillosis: results of multicenter study
by: N. N. Klimko, et al.
Published: (2014-09-01)

Global, regional, and national disease burden of lymphoma and leukemia attributable to high body mass index: from 1990 to 2021
by: Li Zhou, et al.
Published: (2025-07-01)

Immune and Inflammation Markers as a Predictor of Overall Survival in Patients with Hematologic Malignancies: A Retrospective Cohort Study
by: Mehmet Ali Ucar, et al.
Published: (2025-05-01)

Do We Need Meropenem Treatment Beyond 7 Days in Febrile Neutropenic Patients: A Cost-Effectiveness Analysis
by: Leyla Yumrukaya, et al.
Published: (2025-06-01)

Unveiling the Burden of Leukemia in Eritrea (2010–2020): Chronic Leukemia Stability, Rising ALL Incidence, and the Enigma of CML in a Low‐Resource Setting
by: Daniel Mebrahtu Abraha, et al.
Published: (2025-06-01)

Effect of Obesity on Hematological Parameters in Females from Babylon Province
by: Mohammed Ali Al-Jabory, et al.
Published: (2025-04-01)

Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions
by: G. R. Hachatryan, et al.
Published: (2019-01-01)

An impact of CMV and HHV-6 reactivation on the course of early period after hematopoietic stem cell transplantation in patients with hematologic malignancies
by: T. V. Antonova, et al.
Published: (2023-01-01)

Evaluation of some biochemical and Hematological parameters for Changes Associated with Diarrhea in Calves
by: Zeena Ebraheem mohammed Abed, et al.
Published: (2020-02-01)

Colistine pharmacokinetics and Colistimethate sodium daily dose calculation in children with chemotherapy induced neutropenia
by: V. I. Zakharevich, et al.
Published: (2014-09-01)